MERCK FDA Approval NDA 020752

NDA 020752

MERCK

FDA Drug Application

Application #020752

Documents

Letter1998-05-28
Review2005-06-23
Review2007-07-09
Letter2002-06-06
Label1998-05-28
Label2002-06-06
Review1999-03-18

Application Sponsors

NDA 020752MERCK

Marketing Status

Discontinued001
Discontinued002

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL20MG0PEPCID RPDFAMOTIDINE
002TABLET, ORALLY DISINTEGRATING;ORAL40MG0PEPCID RPDFAMOTIDINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1998-05-28STANDARD
LABELING; LabelingSUPPL2AP1999-03-18STANDARD
LABELING; LabelingSUPPL3AP2000-11-27STANDARD
LABELING; LabelingSUPPL4AP2001-04-25STANDARD
EFFICACY; EfficacySUPPL5AP2002-06-06STANDARD
LABELING; LabelingSUPPL6AP2001-03-14STANDARD

Submissions Property Types

SUPPL5Null6

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20752
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.